BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Liver
,
DNA fingerprint
,
Valproic acid
,
rs2300478
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tyr
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Calvaria of wildtype and b-arrestin knockouts treated with G Protein-Coupled Receptor Agonist
Osteocyte-like IDG-SW3 cells after PTH treatment
Irides of mouse models for albinism, pigment dispersion syndrome, and exfoliation syndrome
Cutaneous melanomas derived from induced expression of Met or HRAS
Hippocampal gene expression in a mouse model for Potocki-Lupski Syndrome
Explore Curated Studies Results
Literature
Most Relevant Literature
Does Early Glasses Wear Improve Visual Outcome in OCA1A?
Influence of ultrasound to the activity of tyrosinase.
Mutational analysis of TYR gene and its structural consequences in OCA1A.
Molecular inhibitory mechanism of tricin on tyrosinase.
The oxidation of phenylhydrazine by tyrosinase.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of TYR Sphere
Evaluation of TYR Sphere in France
Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate
GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR
Modulating Glucose Tolerance With Dietary Tyrosine
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ